Lexotanil

Bromazepam, the active ingredient in Lexotanil, is a benzodiazepine presented as an oral tablet for oral use. It is used to relieve anxiety symptoms in adult patients.

GNH USA supplies Lexotanil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Bromazepam acts on the central nervous system to alleviate anxiety and related conditions.

- Anxiety disorders: reduces excessive worry and tension in patients with generalized anxiety disorder or similar conditions. - Acute anxiety episodes: provides rapid short‑term relief of heightened anxiety symptoms. - Pre‑operative anxiety: helps calm patients before surgical procedures when prescribed.

Bromazepam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Fatigue: general sense of tiredness. - Dizziness: light‑headed sensation, especially when standing quickly. - Impaired coordination: reduced motor control or clumsiness. - Memory disturbances: difficulty recalling recent events. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing, particularly when combined with other depressants. - Severe hypotension: marked drop in blood pressure. - Paradoxical reactions: agitation, aggression or increased anxiety. - Dependence and withdrawal: physical dependence with withdrawal symptoms on abrupt cessation. - Hepatic dysfunction: abnormal liver enzyme elevations. - Allergic reactions: rash, itching, swelling or anaphylaxis.

Before prescribing bromazepam, clinicians should consider several precautionary measures to ensure safe use.

- Assess renal and hepatic function: adjust dose if impairment is present. - Evaluate for history of substance abuse: risk of dependence may be higher. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal. - Caution in elderly patients: increased sensitivity to sedative effects. - Contraindicate in severe respiratory insufficiency: may exacerbate breathing problems. - Store at ambient temperature: keep tablets in original container, protect from moisture and light.

Bromazepam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Opioids: combined use can cause profound respiratory depression. - Other benzodiazepines: additive sedative effects increase risk of overdose. - Barbiturates: may enhance central nervous system depression. - Antidepressants with serotonergic activity: potential for increased sedation.

Moderate Interactions (Monitor Closely): - Antihistamines: may increase drowsiness. - Anticonvulsants (e.g., carbamazepine): can reduce bromazepam plasma levels. - Alcohol: enhances sedative effects, caution advised. - CYP3A4 inhibitors (e.g., ketoconazole): may raise bromazepam concentrations.